X0304 4 2012-01-27 0000921847 HUDSON CITY BANCORP INC HCBK 0001537944 Nettleton J. Christopher WEST 80 CENTURY ROAD PARAMUS NJ 07652 0 1 0 0 Senior Vice President Common Stock, par value $0.01 per share 2012-01-27 4 F 0 1356 6.83 D 59627 D Common Stock, par value $0.01 per share 23421 I By ESOP Common Stock, par value $0.01 per share 17426 I By PIB Common Stock, par value $0.01 per share 6372 I By Spouse/PIB Common Stock, par value $0.01 per share 5849 I By Spouse/ESOP Stock Option (Right to Buy) 10.33 2005-01-13 2014-04-14 Common Stock 128240 128240 D Stock Option (Right to Buy) 12.76 2009-07-21 2016-07-20 Common Stock 100000 100000 D Stock Option (Right to Buy) 12.76 2009-01-20 2016-07-20 Common Stock 50000 50000 D Stock Option (Right to Buy) 15.69 2011-01-25 2018-01-24 Common Stock 50000 50000 D Stock Option (Right to Buy) 12.03 2012-01-24 2019-01-22 Common Stock 45000 45000 D Stock Option (Right to Buy) 13.78 2010-01-26 2017-01-25 Common Stock 45000 45000 D Stock Option (Right to Buy) 11.17 2006-01-13 2015-01-20 Common Stock 32060 32060 D Shares held in the reporting person's account in the Hudson City Savings Bank Profit Incentive Bonus Plan. Shares held in the reporting person's spouse's account in the Hudson City Savings Bank Profit Incentive Bonus Plan. The reported transaction represents shares withheld by the issuer to satisfy payroll tax withholding obligations upon vesting of common stock pursuant to the Hudson City Bancorp, Inc. 2006 Stock Incentive Plan. Performance Stock Option grant, on 3/15/11, to purchase 12,300 shares of common stock at $9.50 per share. These options have a 10-yr term ending 3/14/21 and become exercisable on 3/15/14. Performance Deferred Stock Unit award, on 3/15/11, for 9,100 shares of common stock which will vest on 3/15/14. Performance Stock Option grant, on 1/19/10, to purchase 50,000 shares of common stock at $13.12 per share. These options have a 10-yr term ending 1/18/20 and become exercisable on 1/19/13. Terms may end earlier than 10 years in certain circumstances. Vesting is tied to satisfaction, by the exercisable dates, and approval by the Company's Compensation Committee, of certain corporate performance measures specific to each grant and award, and continuous service by the reporting person through such dates. Under applicable SEC regulations, these option grants and awards are reportable in Table II of Form 4 only if and when the performance conditions have been satisfied. Veronica A. Olszewski, Attorney-in-fact 2012-01-31